Selecting the Predicate Device for FDA 510(k) Submission: An Advanced Guide

Key Highlights and Tips for 510(k) Predicate Device Selection

The selection of an appropriate predicate device represents one of the most critical strategic decisions in the FDA 510(k) submission process. This choice directly influences your regulatory pathway, testing requirements, development timeline, and ultimately, the likelihood of obtaining 510(k) clearance. A well-chosen predicate device streamlines the path to market, while a poorly selected one can result in rejection, extensive additional testing, or costly resubmission.

For medical device manufacturers seeking 510(k) clearance, understanding the nuances of predicate selection—including primary predicates, reference devices, split predicates, and the use of multiple predicates—is essential for regulatory success.

Understanding Substantial Equivalence and Predicate Devices

What is a Predicate Device?

A predicate device is a legally marketed medical device to which you compare your new device to demonstrate substantial equivalence. According to FDA regulations (21 CFR 807.92), a valid predicate device must meet one of the following criteria:

Legally marketed before May 28, 1976 (pre-amendments device)
Previously cleared through the 510(k) process
Granted market authorization via the De Novo classification process
Reclassified from Class III to Class II or I

Critically, a device approved through the Premarket Approval (PMA) pathway cannot serve as a predicate device for 510(k) submissions.

The Substantial Equivalence Standard

To obtain 510(k) clearance, your device must be substantially equivalent to the predicate device. The FDA evaluates substantial equivalence based on two fundamental criteria:

1. Same Intended Use

Your device must have the same intended use as the predicate device. The FDA determines intended use primarily from the device labeling, including labels, packaging, inserts, and promotional materials.

2. Technological Characteristics

Your device must either:

Have the same technological characteristics as the predicate, OR
Have different technological characteristics that do not raise new questions of safety and effectiveness, AND you must demonstrate that the device is as safe and effective as the predicate

Understanding this framework is crucial because it determines what type of testing and documentation your 510(k) submission will require.

Primary Predicate vs. Reference Device: Understanding the Distinction

Primary Predicate Device

The primary predicate device is the legally marketed device that forms the foundation of your substantial equivalence comparison. Key characteristics include:

Single Product Code Requirement: There can only be one primary predicate device per 510(k) submission, which determines the primary product code
Intended Use Alignment: The primary predicate must share the same intended use as your subject device
Technological Similarity: Should have technological characteristics that are the same or most similar to your device
Safety and Effectiveness Benchmark: Serves as the standard against which your device’s safety and effectiveness are measured

When selecting your primary predicate, prioritize devices that:

Are currently on the market (not discontinued)
Have recent 510(k) clearance dates (within the last 5-10 years)
Use well-established test methods and consensus standards
Have no unresolved safety issues or design-related recalls
Have minimal adverse event reports in the MAUDE database

Reference Devices

Reference devices serve a fundamentally different purpose than predicate devices. According to FDA guidance, a reference device is:

NOT a predicate device
A legally marketed device used to provide scientific or technical information
Used to support specific technological characteristics or test methodologies
Applied when your primary predicate lacks certain features that your device includes

When to Use Reference Devices:

Novel Technology Feature: Your device incorporates a technological feature not present in the primary predicate, but this feature exists in another legally marketed device
Test Methodology Support: You need to reference specific testing methods or validation approaches used for a particular component or feature
Material Justification: Your device uses a specific material or coating not used in the primary predicate

Example: If you’re submitting a 510(k) for a hip implant with a hydroxyapatite (HA) coating, but your primary predicate device does not have HA coating, you can use a reference device that incorporates HA coating to support the safety and effectiveness of this specific technological characteristic.

Split Predicates: What They Are and Why They’re Prohibited

Historical Context of Split Predicates

Before the FDA’s 2014 guidance “The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications,” some manufacturers attempted to use “split predicates”—comparing their device to one predicate for intended use and a different predicate for technological characteristics.

Current FDA Position

Split predicates are now explicitly prohibited and considered inconsistent with the 510(k) regulatory standard. The FDA’s rationale includes:

Regulatory Framework: The substantial equivalence standard requires comparison to a single predicate device that encompasses both intended use AND technological characteristics
Safety Concerns: Splitting the comparison creates potential gaps in safety and effectiveness evaluation
Scientific Integrity: The approach undermines the coherence of the substantial equivalence determination

Common Misconceptions

Many manufacturers confuse split predicates with multiple predicates. These are distinct concepts:

Split Predicate (PROHIBITED): Using one device for intended use comparison and a different device for technological characteristics
Multiple Predicates (PERMITTED): Using multiple devices with the same intended use to demonstrate equivalence when combining features

Using Multiple Predicate Devices: Advanced Strategies

When Multiple Predicates Are Appropriate

The FDA permits the use of multiple predicate devices in specific circumstances, as outlined in the 2014 guidance. Multiple predicates may be used when:

Combining Features: Your device combines features from two or more predicate devices with the same intended use into a single new device
- Example: A patient monitor that measures multiple physiological parameters (ECG, SpO2, blood pressure), where each parameter may have been cleared separately in different devices
Multiple Intended Uses: Your device has more than one distinct intended use
- Example: A urinary catheter with an integrated thermometer—the catheter function and temperature measurement serve different clinical purposes
Multiple Indications: Your device seeks multiple indications for use under the same overarching intended use
- Example: A surgical instrument approved for use in multiple anatomical locations

Strategic Considerations for Multiple Predicates

Advantages:

Allows leveraging of established safety and effectiveness data from multiple sources
Provides flexibility when no single predicate encompasses all features
Can strengthen your substantial equivalence argument by showing consistency across multiple cleared devices

Challenges:

Increased complexity in submission documentation
Greater review burden for FDA, potentially extending review timelines
Must clearly demonstrate that combining features does not alter the risk profile
Requires careful justification of why multiple predicates are necessary

FDA’s Preference for Single Predicates

Despite permitting multiple predicates, the FDA encourages manufacturers to use a single predicate whenever possible. Benefits include:

Streamlined substantial equivalence comparison
Clearer regulatory pathway
Reduced documentation burden
Potentially faster review times
Lower risk of raising new questions of safety and effectiveness

Best Practices for Predicate Device Selection (2023 FDA Guidance)

In September 2023, the FDA released draft guidance introducing four “best practices” for predicate selection, signaling a significant modernization of the 510(k) program. While still in draft form, these recommendations provide valuable insight into FDA’s expectations.

The Four Best Practices

1. Well-Established Methods

Select a predicate device that was cleared using well-established testing methods, such as:

Recognized consensus standards (ISO, ASTM, IEC standards)
FDA-issued guidance documents
Established scientific methodologies with peer-reviewed validation

Why it matters: Using predicates with well-established test methods reduces regulatory uncertainty and provides clear benchmarks for your testing protocols.

2. Current Safety and Performance Expectations

Ensure your predicate continues to meet or exceed safety and performance expectations by reviewing:

Post-market surveillance data (MAUDE database)
Design-related malfunction reports
Adverse event patterns
Field safety corrective actions

Why it matters: Predicates with strong post-market safety profiles reduce the risk of FDA questioning the appropriateness of your comparison.

3. No Unmitigated Safety Issues

Verify that your predicate does not have unmitigated use-related or design-related safety issues by checking:

FDA safety communications (safety alerts, public health notifications)
MedWatch reports
Manufacturer field safety notices
FDA warning letters related to the device

Why it matters: Using a predicate with unresolved safety concerns can jeopardize your entire submission and may prompt FDA to request additional safety data.

4. No Design-Related Recalls

Confirm your predicate is not subject to design-related recalls by searching:

FDA Recalls Database
Manufacturer recall announcements
FDA Enforcement Reports

Why it matters: Design-related recalls indicate fundamental issues with the device architecture that could undermine your substantial equivalence claim.

Documenting Your Predicate Selection Rationale

The draft guidance recommends including a narrative in your 510(k) submission that explains:

How you identified potential predicates
How you applied the four best practices
Why you selected your final predicate(s) over alternatives
A comparison table of all valid predicates assessed

This documentation demonstrates due diligence and strengthens your submission’s credibility.

Practical Tips for Successful Predicate Selection

1. Start with Product Code Identification

Step-by-step approach:

a) Use the FDA Product Classification Database to identify your device’s product code

Search by device name, intended use, or medical specialty panel
Review the classification regulation (21 CFR citation)
Note the device class (I, II, or III)

b) Verify whether exemptions apply

Some Class I and II devices are exempt from 510(k) requirements
Check for specific exemption limitations in the regulation

c) Understand any special controls

Class II devices may have special controls (specific guidance, performance standards)
These will influence your testing requirements

2. Search the 510(k) Database Strategically

Search optimization techniques:

Use Boolean operators: Combine keywords with AND, OR operators for precise results
Filter by date: Prioritize recent clearances (last 5-10 years) for more modern predicates
Examine multiple variations: Search for similar device names, synonyms, and related technologies
Review applicant names: Identify major manufacturers in your device category
Export and compare: Download search results to spreadsheet for systematic comparison

Key fields to review in 510(k) summaries:

Indications for Use statement (must match yours closely)
Device description and technological characteristics
Performance testing conducted (guides your test strategy)
Consensus standards referenced
Clinical data requirements (if any)

3. Avoid Common Predicate Selection Pitfalls

Pitfall #1: Selecting Discontinued or Obsolete Devices

While FDA regulations permit using devices no longer on the market as predicates, this approach carries significant risks:

Difficult to obtain predicate device samples for comparative testing
May use outdated technology or testing methods
Raises questions about why the device was discontinued
May have undisclosed safety or manufacturing issues

Pitfall #2: Choosing Predicates with Different Product Codes

Although some 510(k)s successfully use predicates with different product codes under the same regulation number, this approach significantly complicates the substantial equivalence argument:

Increases scrutiny from FDA reviewers
Requires extensive justification
May indicate different intended uses or technological characteristics
Generally advisable only when no same-product-code predicate exists

Pitfall #3: Over-Engineering the Comparison

Some manufacturers select very basic predicates thinking it will be easier to demonstrate superiority. However:

Your device still must be substantially equivalent, not better
Significant improvements may raise new questions of safety and effectiveness
May require more extensive clinical data to support novel features
Could inadvertently push you toward De Novo or PMA pathway

Pitfall #4: Ignoring Post-Market Data

Failing to review MAUDE reports, recalls, and safety communications for your predicate:

FDA reviewers will examine this data
Safety issues with your predicate undermine your submission
May prompt additional testing requirements or NSE determination
Demonstrates lack of due diligence

4. Build a Predicate Comparison Strategy

Create a predicate evaluation matrix:

Criteria	Predicate A	Predicate B	Predicate C	Your Device
Product Code	XXX	XXX	YYY	XXX
Clearance Date	2022	2019	2024	N/A
Intended Use	[Details]	[Details]	[Details]	[Details]
Key Technologies	[Details]	[Details]	[Details]	[Details]
Materials	[Details]	[Details]	[Details]	[Details]
Test Standards Used	[List]	[List]	[List]	[Planned]
MAUDE Reports (5yr)	15	87	3	N/A
Active Recalls	None	1 (non-design)	None	N/A
Currently Marketed	Yes	Yes	Yes	N/A
Availability for Testing	Yes	Limited	Yes	N/A

Scoring system: Assign weighted scores to each criterion based on importance for your device.

5. Plan Testing Requirements Based on Predicate

Your predicate selection directly determines your testing strategy:

If your device is identical to the predicate:

Minimal additional testing required
Focus on manufacturing validation and design verification
May qualify for Abbreviated 510(k) if relying on consensus standards

If your device has minor technological differences:

Targeted testing to address specific differences
Bench testing typically sufficient
Biocompatibility testing if materials differ
Software validation if applicable

If your device has significant technological differences:

Extensive performance testing required
May need clinical data to support substantial equivalence
Animal testing for implants or invasive devices
Durability and longevity testing
Human factors and usability studies

6. Consider Pre-Submission Meeting with FDA

For complex devices or novel predicate comparisons:

When to request a Pre-Sub:

Uncertain whether your predicate choice is appropriate
Planning to use multiple predicates
Significant technological differences from predicate
Novel intended use interpretation
Unclear testing requirements

Benefits:

Direct FDA feedback on predicate selection
Clarification of testing expectations
Risk mitigation before full submission
Documentation of FDA agreement (Q-Sub)

Frequently Asked Questions (FAQs)

Can I use two or more predicate devices in my 510(k) submission?

Yes, you can use multiple predicate devices, but only under specific circumstances:

When combining features from multiple devices with the same intended use
When your device has multiple distinct intended uses
When seeking multiple indications under the same intended use

However, the FDA encourages using a single predicate whenever possible. If using multiple predicates, you must clearly justify why this approach is necessary and demonstrate that combining features does not alter the risk profile relative to each predicate.

Important: You cannot use “split predicates” (one predicate for intended use and another for technological characteristics)—this practice is explicitly prohibited.

What is the difference between a primary predicate and a reference device?

Primary Predicate:

The main device used to demonstrate substantial equivalence
Determines your product code
Must share the same intended use as your device
You compare both intended use AND technological characteristics

Reference Device:

NOT a predicate device
Provides supporting technical or scientific information
Used for specific features not present in primary predicate
Does not establish substantial equivalence on its own

Example: Your primary predicate is a surgical drill. Your device has the same drilling mechanism but includes a novel irrigation system. You use a reference device that has a similar irrigation system to support the safety and effectiveness of this specific feature.

Can my predicate device be from a different product code than my device?

Generally not recommended, but possible in limited circumstances:

Same regulation number (21 CFR citation) is typically required
Different product codes usually indicate different intended uses or technological characteristics
Significantly complicates the substantial equivalence argument
Requires extensive justification in your submission
Increases risk of NSE (Not Substantially Equivalent) determination

Best practice: Select a predicate with the same product code. If none exists, consider:

Whether De Novo classification is more appropriate
Whether you’ve correctly identified your device’s product code
Consulting with regulatory experts before proceeding

What if my predicate device has been recalled?

This depends on the type and status of the recall:

Non-design related recalls (e.g., labeling issues, manufacturing problems):

Generally acceptable if the issue has been corrected
Include explanation in your submission
May need to address how your device avoids similar issues

Design-related recalls:

FDA’s 2023 draft guidance recommends avoiding these predicates
Indicates fundamental design flaws that undermine substantial equivalence
If you must use such a predicate, provide extensive justification
Demonstrate how your device addresses the design issue
Expect additional scrutiny and potentially longer review

Best practice: Select a predicate without any recalls. If all potential predicates have recalls, document this thoroughly and explain your selection rationale.

Can I use a predicate device that is no longer on the market?

Yes, legally permitted, but carries significant practical challenges:

Regulatory perspective:

FDA regulations allow predicates no longer commercially distributed
Must still be a “legally marketed” device (not in violation of FD&C Act)

Practical challenges:

Difficult or impossible to obtain samples for comparative testing
May use outdated testing methodologies
Unclear why device was discontinued (safety issues? commercial failure?)
May face additional scrutiny from FDA reviewers
Harder to justify as appropriate comparison

When it might be acceptable:

Device discontinued for commercial reasons unrelated to safety/effectiveness
Recent clearance before discontinuation
You have access to device samples and comprehensive technical documentation
No currently marketed alternative exists

Best practice: Prioritize currently marketed predicates. If using discontinued device, thoroughly research and document the reason for discontinuation.

How recent should my predicate device’s 510(k) clearance be?

While there’s no explicit FDA requirement, best practices suggest:

Optimal timeline:

Last 5-10 years: Ideal—reflects current standards and technology
Last 10-15 years: Acceptable if technology hasn’t significantly evolved
15+ years: Use with caution—may be considered outdated

Considerations:

Pace of technological advancement in your device category
Updates to consensus standards and testing methods
Evolution of clinical practice and safety expectations
FDA guidance documents issued since predicate clearance

FDA’s 2023 draft guidance emphasizes:

Using predicates cleared with well-established methods
Avoiding outdated technology
Considering post-market performance over time

Strategic approach: If all predicates are older, consider:

Whether your device represents significant advancement (De Novo pathway?)
Selecting the most recent among available options
Supplementing with reference devices for specific modern features
Addressing technology evolution in your submission

Do I need to conduct comparative testing between my device and the predicate?

It depends on the differences between devices:

Minimal or no differences:

Direct comparison may not be necessary
Design verification/validation typically sufficient
Reference predicate’s performance data in your submission

Minor technological differences:

Targeted comparative testing for specific differences
Side-by-side bench testing often required
Use same test methods as predicate when possible

Significant technological differences:

Comprehensive comparative testing required
Head-to-head performance comparisons
Clinical data may be necessary
Must demonstrate device is “as safe and effective”

Testing strategy:

Review predicate’s 510(k) summary for test methods used
Use same consensus standards to ensure valid comparison
Document why your testing demonstrates equivalence
Consider obtaining predicate device samples for direct comparison

What is a “valid predicate device”?

The FDA’s 2023 draft guidance introduced the concept of “valid predicate device,” which goes beyond simply being legally marketed:

Legal requirements (minimum):

Legally marketed in the U.S.
Previously cleared via 510(k) or De Novo, or pre-amendments device
Not a PMA-approved device
Not in violation of FD&C Act

Best practices for validity (FDA recommendations):

Cleared using well-established methods
Continues to meet safety/performance expectations
No unmitigated safety issues
No design-related recalls

Validation process:

Search 510(k) database for potential predicates
Review MAUDE database for adverse events
Check FDA Recalls database
Review safety communications
Assess ongoing market presence
Evaluate test methods used in clearance

Documentation: The draft guidance recommends creating a table showing how each potential predicate meets (or doesn’t meet) the best practices criteria, with your rationale for final selection.

Can I change my predicate device during FDA review?

Generally problematic but possible in limited circumstances:

During review:

FDA may question appropriateness of your selected predicate
You can propose alternative predicate in response to questions
May require submitting amended 510(k) or new data
Likely extends review timeline significantly

After NSE (Not Substantially Equivalent) determination:

You can submit new 510(k) with different predicate
Treat as completely new submission
Use lessons learned from first submission
May be faster than attempting to appeal NSE

Best practices to avoid changing predicates:

Conduct thorough predicate research before submission
Consider Pre-Submission meeting for complex cases
Have alternative predicates identified before submission
Document comprehensive predicate selection rationale

If change becomes necessary:

Act quickly when FDA raises concerns
Provide clear justification for new predicate
Submit all comparative data with new predicate
Be prepared for extended review or resubmission

How do I handle a situation where my device improves upon the predicate?

This is a common misconception about 510(k)—you’re not demonstrating superiority, but equivalence:

Key principle: Your device must be “at least as safe and effective” as the predicate, not necessarily better.

If improvements raise new questions:

Novel mechanism of action → May not be eligible for 510(k)
Significantly enhanced performance → Justify why it doesn’t raise new safety questions
New patient population → Likely different intended use (not equivalent)
Different risk profile → May require De Novo or PMA pathway

If improvements don’t raise new questions:

Minor enhancements (ergonomics, usability) → Acceptable
Better materials with established safety → Use reference device for material
Incremental performance improvements → Demonstrate through testing
Reduced procedure time → Show doesn’t compromise safety

Documentation strategy:

Explicitly address each improvement
Explain why changes don’t raise new safety/effectiveness questions
Provide test data showing equivalence in critical parameters
Consider potential FDA concerns proactively

Alternative pathways if improvements are substantial:

De Novo: For novel, low-to-moderate risk devices
PMA: For high-risk devices or significant innovations
Breakthrough Device designation: For significant innovations addressing unmet needs

Conclusion: Strategic Approach to Predicate Selection

Selecting the appropriate predicate device requires a systematic, strategic approach that balances regulatory requirements, scientific validity, and practical considerations. Success in predicate selection sets the foundation for your entire 510(k) submission and significantly impacts your path to market.

Key takeaways for regulatory professionals:

Start early: Begin predicate research during device design phase, not after development is complete
Be systematic: Use FDA databases comprehensively, document your search strategy, and evaluate multiple candidates
Prioritize quality: Choose predicates with recent clearances, strong post-market safety records, and current technology
Understand distinctions: Recognize the differences between primary predicates, reference devices, multiple predicates, and split predicates (prohibited)
Plan testing accordingly: Your predicate choice determines your testing strategy and submission complexity
Document thoroughly: FDA increasingly expects detailed rationale for predicate selection, especially following 2023 draft guidance
Stay current: Monitor FDA guidance updates, particularly regarding predicate selection best practices
Consider alternatives: If no appropriate predicate exists, evaluate De Novo or PMA pathways rather than forcing a weak substantial equivalence argument

The 510(k) pathway, when navigated with a well-chosen predicate device, remains the most efficient route to U.S. market access for most Class II medical devices. By applying the principles and strategies outlined in this guide, regulatory professionals can make informed predicate selections that withstand FDA scrutiny and accelerate time to market.

About This Article

This advanced guide is designed for regulatory affairs professionals, quality assurance managers, and medical device developers with foundational knowledge of the FDA 510(k) process. For basic introduction to 510(k) submissions, consult FDA’s “The Beginner’s Guide to the FDA 510(k)” or similar introductory resources.

Last updated: February 2026